Keyphrases
Akt-mTOR Signaling
100%
AKT1
33%
Diabetic
16%
Diabetic Nephropathy
16%
ERK2
16%
GH Receptor
33%
GH-IGF
16%
Growth Factors
16%
Growth Hormone
50%
Growth Hormone Receptor
16%
Insulin-like Growth Factor 1 Receptor (IGF1R)
100%
Insulin-like Growth factor-1
66%
JAK2-STAT5
33%
Janus Kinase 2 (JAK2)
16%
Kidney
16%
Kidney Tissue
16%
Mammalian Target of Rapamycin (mTOR)
33%
Mapk
33%
MAPK Signaling
100%
MRNA Level
33%
Nephropathy
16%
P-STAT3
16%
Receptor Activation
100%
Receptor Phosphorylation
16%
Receptor Signaling
16%
Renal Growth
16%
RPS6
50%
Signaling Molecules
16%
Type 1 Diabetic
16%
Type I Diabetes
100%
Medicine and Dentistry
Akt/mTOR Signaling
100%
Diabetes Mellitus
16%
Diabetic Nephropathy
16%
Glycogen Synthase Kinase
16%
Growth Factor
16%
Growth Hormone
50%
Growth Hormone Receptor
16%
Insulin Dependent Diabetes Mellitus
100%
Janus Kinase
50%
Kidney Development
16%
Kidney Tissue
16%
Mammalian Target of Rapamycin
33%
MAPK Signaling
100%
Messenger RNA
33%
Mitogen-Activated Protein Kinase
16%
Nephropathy
16%
Receptor
33%
Signaling Molecule
16%
Somatomedin C Receptor
100%
Pharmacology, Toxicology and Pharmaceutical Science
Diabetes Mellitus
16%
Diabetic Nephropathy
16%
Glycogen Synthase Kinase
16%
Growth Factor
16%
Growth Hormone
50%
Growth Hormone Receptor
16%
Insulin Dependent Diabetes Mellitus
100%
Janus Kinase
50%
Kidney Disease
16%
Messenger RNA
33%
Receptor
33%
Somatomedin C Receptor
100%
Immunology and Microbiology
Akt/mTOR Signaling
100%
Growth Factor
16%
Insulin-Like Growth Factor 1 Receptor
100%
Kidney Development
16%
Kidney Tissue
16%
MAPK Signaling
100%
STAT5
50%